Brussels, February 16, 2026 – The European Food Safety Authority (EFSA) has today published a preliminary safety value for daily CBD intake as a novel food. The European Industrial Hemp Association (EIHA) welcomes this step as an important regulatory advance, but criticizes the dosing limit as „particularly conservative.“
📑 Inhaltsverzeichnis
After years of uncertainty and a temporary halt to review procedures in 2022, there is now a first scientific guideline for the EU market. The EFSA has set the preliminary safety value at 0.0275 mg per kilogram of body weight per day. For an average-weight adult (70 kg), this corresponds to a daily amount of approximately 2 mg CBD.
An Important, Yet Conservative Step
The EIHA views the EFSA’s announcement as confirmation that a safe consumption level for CBD exists. Nevertheless, the association emphasizes that the established value falls significantly short of recommendations from other regions. For comparison: the British Food Standards Agency (FSA) recommends a limit of 10 mg per day – five times the value now proposed by the EFSA.
„The establishment of a safety value now provides the clear scientific and regulatory basis to finally advance the approval process for CBD isolates in the EU,“ the EIHA stated in its position paper.
EIHA Advocates for Science-Based 17.5 mg Daily Dose
As part of its own novel food dossier, the EIHA has submitted extensive toxicological studies supporting a daily dose of 17.5 mg as safe. The association announced it will work closely with the EFSA and the EU Commission to address remaining data gaps through additional high-quality studies. The goal remains to achieve approval based on this scientifically substantiated, higher threshold.
Approval Targeted for End of Year
Despite the strict classification, the EIHA remains optimistic. The organization expects current approval applications for CBD isolates to now proceed expeditiously on the basis of the preliminary 2 mg value. EIHA partners are currently finalizing the remaining information required by the EFSA.
The industry’s stated goal: final approval for CBD as a novel food in the European Union – ideally before the end of 2026. This would finally give European consumers legal certainty and access to tested, high-quality CBD products.












































